http://jcps.bjmu.edu.cn

• 研究论文 • 上一篇    下一篇

商陆多糖I对给环磷酰胺及60Co照射小鼠造血功能的保护作用

王洪斌, 郑钦岳, 孙盛川, 刘宝云, 沈有安, 唐惠兰, 鞠佃文, 方军   

  1. 1. 上海第二军医大学药学院药理教研室, 上海 200433;
    2. 上海第二军医大学长征医院药局, 上海 20002
  • 收稿日期:1993-08-24 修回日期:1994-11-28 出版日期:1995-06-15 发布日期:1995-06-15

Protective Effect of phytolacca Acinosa Polysaccharides I(PAP-I) on Hematopoiesis in Cyclophosphamide-treated and 60Co-irradiated Mice

Hong-Bin Wang, Qin-Yue Zheng, Sheng-Chuan Sun, Bao-Yun Liu, You-An Shen, Hui-Lan Tang, Dian-Wen Ju, Jun Fang   

  1. 1. Department of pharmacology; College of Pharmacy; Second Military Medical University; Shanghai 200433;
    2. Department of Pharmacy; Chang Zhen Hospital, Second Military Medical University, Shanghai 20002
  • Received:1993-08-24 Revised:1994-11-28 Online:1995-06-15 Published:1995-06-15

摘要: 正常小鼠给商陆多糖I (PAP-I), 10 mg/kg每周3, 给药一周后, 腹腔注射cyclophosphamide (CY), 300 mg/kg, 小鼠的平均存活时间由13.3±7.2 d延长至36.7±16.4 d, (CY)100 mg/kg, ip分别在d7, d16, d26给予能显著降低小鼠外周血白细胞, 经用PAP-I(方案同上), 可显著促进其外周血白细胞数回升, sarcoma180小鼠经CY 10 mg/kg或加PAP-I, 10 mg/kg治疗10 d, 分别于不同时间检测外周白细胞数, 结果表明与对照组相比单独用CY治疗的小鼠外周白细胞数显著降低, 合用PAP-I可显著对抗CY的降低白细胞效应, 取上述小鼠骨髓细胞计数骨髓有核细胞并用[3H] TdR细胞参入法检测骨髓细胞对重组鼠粒单系集落刺激因子的增殖能力, 结果表明PAP-I+CY组的骨髓有核细胞细胞数及[3H] TdR参入的dpm值均显著高于单用CY组。小鼠于60Co照射前和/或照射后ip PAP-I, 10 mg/kg每周3, 结果证实PAP-I能显著促进造血功能重建, PAP-I给药组的脾节结数(CFU-S8CFU-S12) rm GM-CSF诱导骨髓细胞增殖的dpm值均显著高于对照组, PAP-I, 10 mg/kg ip能显著升高外周白细胞, 促进外周血集落刺激因子产生, IL-3, GM-CSF单克隆抗体及M-CSF多克隆抗体吸收实验表明血清中CSF类型主要为M-CSF。以上结果提示PAP-I具有造血功能的保护作用, 可望用于临床放疗及化疗的辅助治疗。

关键词: 商陆多糖, 外周血白细胞, 环磷酰胺, 60Co, γ射线, CFU-S, 单克抗体, 多克隆抗体, 集落刺激因子

Abstract: The protective effect of a kind of purified polysaccharides extracted from Radix of Phytolacca acinosa Roxb, with a molecular weight of 10 KDa, on hematopoiesis was investigated.Average survival time of mice treated with cyclophosphamide (CY) 300 mg/kg once alone was 13.3±7.2 d (n = 7) however, average survival time of mice treated with CY 300 mg/kg in com-bination with PAP-1 10 mg/kg, 3 times/wk was 36.7±16.4 d (n = 7, P<0.01). PAP-1, ip had benefi-cial effect on the recovery of the CY induced decrease of peripheral leukocyte number, and the nu-cleated bone marrow cell(BMC)number and [3H]TdR uptaken by BMC induced by rmGM-CSF in S180 bearing mice treated with CY, In mice, after the first ip treatment with CY 100 mg/kg on d7, the peripheral leukocyte number decreased on d9 and recovered to normal level about d13 to d15. Such recovery was accelerated by administrating PAP-1, 10 mg/kg, 3 times/wk. A significant in-crease of the activity to form colony in spleen(colony-forming unit in spleen, CFU-S8, CUF-S12 in mice irradiated with 550 rad 60Co γ-rays and an enhancement of proliferative response of BMC to rm GM-CSF treated with PAP-1, 10 mg/kg, 3 times/wk, ip were observed.After PAP-1, 10 mg/kg, ip once, a significant increase in the number of peripheral blood leukocytes and a rise in the serum of colony stimulating factor (CSF) were also confirmed.The types of CSF in serum were M-CSF and other hematopoietic growth factors, which were confirmed by using McAb of IL-3, GM-CSF and PcAb of M-CSF. These beneficial effects of PAP-1 on hematopoiesis may be related to its activityinducing CSFs and other hematopoietic growth factors and warrant further evaluation of its use-fulness.

Key words: Phytolacca acinosa, Polysaccharides, Cyclophosphamide, Colony-forming unit in spleen(CFU-S), Colony stimulating factors, Monocolonal antibody, Polycolonal antibody

Supporting: